Den Lille Onkolog Onkologisk afdeling Odense ... - Kemoland
Den Lille Onkolog Onkologisk afdeling Odense ... - Kemoland
Den Lille Onkolog Onkologisk afdeling Odense ... - Kemoland
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2<br />
3.8 Gynækologisk <strong>Onkolog</strong>i ................................................................................................ 93<br />
3.8.1 Ovariecancer............................................................................................................ 93<br />
3.8.2 Corpus utericancer .................................................................................................. 95<br />
3.8.3 Cervix utericancer ................................................................................................... 96<br />
3.8.4 Vaginalcancer.......................................................................................................... 99<br />
3.8.5 Vulvacancer........................................................................................................... 100<br />
3.9 CNS-tumorer ................................................................................................................ 100<br />
3.10 Hæmatologi ................................................................................................................ 104<br />
3.10.1 Akut myeloid leukæmi (AML) ........................................................................... 104<br />
3.10.2 Myelodysplastiske syndromer (MDS) ................................................................ 107<br />
3.10.3 Kronisk myeloid leukæmi (CML)....................................................................... 108<br />
3.10.4 Myelofibrose ....................................................................................................... 109<br />
3.10.5 Polycythaemia vera ............................................................................................. 110<br />
3.10.6 Akut lymfatisk leukæmi (ALL)........................................................................... 110<br />
3.10.7 Kronisk lymfatisk leukæmi (CLL)...................................................................... 111<br />
3.10.8 Hodgkin's sygdom............................................................................................... 114<br />
3.10.9 Lymphoma malignum non-Hodgkin (NHL) ....................................................... 115<br />
3.10.10 Myelomatose ..................................................................................................... 118<br />
3.11 Maligne sygdomme hos børn ..................................................................................... 120<br />
3.12 Metastase fra ukendt primærtumor ............................................................................ 121<br />
4. BEHANDLING.................................................................................................................. 124<br />
4.1 Palliativ behandling...................................................................................................... 124<br />
4.2 Strålebehandling........................................................................................................... 125<br />
4.2.1 Standardfelter og standarddoser............................................................................ 125<br />
4.2.2 Bivirkninger og komplikationer ved strålebehandling.......................................... 132<br />
4.2.3 Organspecifikke strålebivirkninger....................................................................... 135<br />
4.3 Cytostatika.................................................................................................................... 141<br />
4.3.1 Alfabetisk gennemgang af de enkelte cytostatika................................................. 141<br />
4.4 Understøttende behandling........................................................................................... 165<br />
4.4.1 Kvalme/opkastning................................................................................................ 165<br />
4.4.2 Smertebehandling ved cancersygdomme .............................................................. 169<br />
4.4.3 Hormonel substitutionsbehandling........................................................................ 174<br />
4.4.4 Parenteral ernæring ............................................................................................... 176<br />
4.4.5 Behandling af infektioner hos patienter med granulocytopeni ............................. 176<br />
eller anden sværere immundefekt .................................................................................. 176<br />
4.4.6 Antikoagulationsbehandling ved dyb venetrombose ............................................ 180<br />
4.4.7 Forholdsregler ved splenektomi............................................................................ 181<br />
5. AKUTTE ONKOLOGISKE OG HÆMATOLOGISKE TILSTANDE ............................ 183<br />
5.1 Hypercalcæmi ved maligne lidelser ............................................................................. 183<br />
5.2 Hyponatriæmi............................................................................................................... 184<br />
5.3 Vena Cava Superior Syndrom...................................................................................... 185<br />
5.4 Perikardiel tamponade.................................................................................................. 185<br />
5.5 Behandlingsinduceret hjerteinsufficiens (anthracykliner) ........................................... 186<br />
5.6 Hjernemetastaser .......................................................................................................... 186<br />
5.7 Meningeal karcinomatose ............................................................................................ 187<br />
5.8 Medullært spinalt tværsnitssyndrom............................................................................ 188<br />
5.9 Behandling af kramper................................................................................................. 189<br />
<strong>Den</strong> lille <strong>Onkolog</strong>, <strong>Odense</strong> 2003